Impact of Pentoxifylline and Vitamin E on Ribavirin-Induced Haemolytic Anaemia in Chronic Hepatitis C Patients: An Egyptian Survey

Table 2

Comparison of patient profiles and laboratory data in both groups.

Variable	Group 1 (vit E and pentoxifylline) n : 100	Group 2 (control) n : 100	𝑃 value
Age (years)	44.3±12.3	45.9±10.3	NS
Sex M : F	69 : 31	58 : 42	NS
BMI kg/m^2	26.8±5.7	27.9±6.1	NS
Peripheral blood cell count
Haemoglobin gm%	14.48±1.64	14.79±1.38	NS
Leukocyte (×10^3/mL)	6.64±1.85	6.67±1.9	NS
Platelet (×10^3/mL)	198.73±62.4	192.21±76.32	NS
Blood biochemistry
AST (IU/L)	72.55±46.82	73.19±39.47	NS
ALT (IU/L)	86.71±67.92	79.66±70.13	NS
Bilirubin (mg/dL)	0.91±0.62	1.02±0.66	NS
Creatinine (mg/dL)	1.13±0.42	0.99±0.38	NS
A.P. (IU/L)	124.3±54.82	132.02±64.7	NS
Iron (mcg/dL)	82.7±60.7	85.6±58.8	NS
Ferritin ng/mL	132.7±42.8	129.64±39.24	NS
Liver Histology
F1-F2	68	62	NS
F3-F4	32	38
HCV-RNA PCR viral load iu/mL
<400,000 iu/mL	66	58	NS
>400,000 iu/mL	34	42
Ribavirin dosage
1000 mg/day	38	29	NS
1200 mg/day	62	71

NS: Non significant (𝑃>.05).